Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Futura Medical presents further detailed data from FM57 phase III study of MED-3000

April 6, 2020

Researchers create rat model of AKI to CKD progression

April 3, 2020

Researchers mimic interstitial cystitis in rat model

April 2, 2020

Dicerna reports initial data from PHYOX 3 long-term extension study of nedosiran for PH

April 1, 2020

Japanese approval of Lokelma for hyperkalemia

March 26, 2020

Promising final phase IIa results presented for IPED-2015 in erectile dysfunction

March 17, 2020

AZD-2373 begins first-in-human trial in healthy male subjects of African ancestry

March 11, 2020

FDA approves Procysbi delayed-release oral granules in packets

Feb. 19, 2020

Allena plans protocol amendment for second pivotal trial of reloxaliase for enteric hyperoxaluria

Feb. 12, 2020

New hydroxyacid oxidase 1 inhibitors discovered at Orfan Biotech

Jan. 28, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...